Skip to main content
    C

    Cerus Corporation (CERS)

    Official site

    HEALTHCARE • MEDICAL DEVICES • NASDAQ

    $2.26
    +0.02 (+0.89%)

    Market Cap: $451.42M

    Last updated: Oct 16, 2026 at 1:54 PM ET

    Earnings

    Performance (10Y)

    Beat Rate
    69%(27/39)
    Avg Surprise
    +5.79%
    Streak
    2 Q

    Upcoming Estimates

    Period ending Sep 30, 2026
    EPS Consensus$-0.01
    Range$-0.02 - $-0.01
    2 analysts
    EPS RevisionsNo revisions (7d)No revisions (30d)
    EPS Estimate DriftChange to current
    90d ago$-0.01-50.0%
    60d ago$-0.01-50.0%
    30d ago$-0.01-50.0%
    7d ago$-0.010.0%
    Current$-0.01
    Revenue Consensus
    $61M
    Range$58M - $63M
    3 analysts
    Period ending Dec 31, 2026
    EPS Consensus$0.01
    Range$0.01 - $0.02
    2 analysts
    Revenue Consensus
    $80M
    Range$61M - $87M
    4 analysts
    PeriodReportedEst.SurpriseB/MYoY
    Dec 26EST
    		-$0.01---
    Sep 26EST
    		-$-0.01---
    Jun 26
    Reported Jul 30
    		$-0.01$-0.01+0.00%Beat+66.7%
    Mar 26
    Reported Apr 30
    		$-0.01N/A+75.00%Beat+75.0%
    Dec 25
    Reported Mar 2
    		$-0.01$-0.01-33.33%Miss+0.0%
    Sep 25
    Reported Nov 6
    		$-0.00N/A+99.50%Beat+99.5%
    Jun 25
    Reported Aug 5
    		$-0.03$-0.02-50.00%Miss+0.0%
    Mar 25
    Reported May 1
    		$-0.04$-0.05+20.00%Beat+20.0%
    Dec 24
    Reported Feb 20
    		$-0.01$-0.01+0.00%Beat+0.0%
    Sep 24
    Reported Oct 30
    		$-0.02$-0.03+33.33%Beat+33.3%
    Jun 24
    Reported Aug 1
    		$-0.03$-0.04+25.00%Beat+50.0%
    Mar 24
    Reported May 2
    		$-0.05$-0.04-25.00%Miss+44.4%
    Dec 23
    Reported Mar 5
    		$-0.01$-0.02+50.00%Beat+87.5%
    Sep 23
    Reported Nov 2
    		$-0.03$-0.05+40.00%Beat+40.0%
    Jun 23
    Reported Aug 2
    		$-0.06$-0.06+0.00%Beat+0.0%
    Mar 23
    Reported May 4
    		$-0.09$-0.07-28.57%Miss-28.6%
    Dec 22
    Reported Feb 28
    		$-0.08$-0.05-60.00%Miss-60.0%
    Sep 22
    Reported Nov 3
    		$-0.05$-0.05+0.00%Beat+28.6%
    Jun 22
    Reported Aug 4
    		$-0.06$-0.06+0.00%Beat+33.3%
    Mar 22
    Reported May 5
    		$-0.07$-0.08+12.50%Beat+30.0%
    Dec 21
    Reported Feb 22
    		$-0.05$-0.08+37.50%Beat+44.4%
    Sep 21
    Reported Nov 2
    		$-0.07$-0.10+30.00%Beat+12.5%
    Jun 21
    Reported Aug 3
    		$-0.09$-0.09+0.00%Beat+0.0%
    Mar 21
    Reported May 4
    		$-0.10$-0.09-11.11%Miss+0.0%
    Dec 20
    Reported Feb 25
    		$-0.09$-0.09+0.00%Beat+25.0%
    Sep 20
    Reported Oct 29
    		$-0.08$-0.10+20.00%Beat+38.5%
    Jun 20
    Reported Aug 4
    		$-0.09$-0.10+10.00%Beat+30.8%
    Mar 20
    Reported May 5
    		$-0.10$-0.10+0.00%Beat+28.6%
    Dec 19
    Reported Feb 20
    		$-0.12$-0.12+0.00%Beat+0.0%
    Sep 19
    Reported Oct 30
    		$-0.13$-0.12-8.33%Miss-18.2%
    Jun 19
    Reported Aug 1
    		$-0.13$-0.12-8.33%Miss-30.0%
    Mar 19
    Reported May 7
    		$-0.14$-0.11-27.27%Miss-27.3%
    Dec 18
    Reported Feb 26
    		$-0.12$-0.11-9.09%Miss-20.0%
    Sep 18
    Reported Nov 1
    		$-0.11$-0.10-10.00%Miss+8.3%
    Jun 18
    Reported Aug 2
    		$-0.10$-0.11+9.09%Beat+37.5%
    Mar 18
    Reported May 8
    		$-0.11$-0.11+0.00%Beat+38.9%
    Dec 17
    Reported Mar 8
    		$-0.10$-0.11+9.09%Beat+23.1%
    Sep 17
    Reported Nov 2
    		$-0.12$-0.16+25.00%Beat-
    Jun 17
    Reported Aug 3
    		$-0.16$-0.16+0.00%Beat-
    Mar 17
    Reported May 3
    		$-0.18$-0.16-12.50%Miss-
    Dec 16
    Reported Mar 7
    		$-0.13$-0.15+13.33%Beat-

    Key Metrics

    Valuation
    P/E Ratio-75.08EV/EBITDA172.01x
    Price/FCF-247.83xFCF Yield-0.40%
    Profitability
    Profit Margin-3.06%Operating Margin-3.24%
    ROE-10.80%ROIC0.91%
    Financial Health
    Debt/Equity0.93xInterest Coverage0.16x
    Current Ratio1.83xQuick Ratio1.07x
    Trading Statistics
    Beta1.83Avg Volume2.01M
    52-Week High$3.4752-Week Low$1.38

    Technical Indicators Dashboard

    Moving Averages

    SMA 10$2.29
    SMA 20$2.41
    SMA 50$2.55
    SMA 200$2.44
    EMA 10$2.30
    EMA 20$2.37
    EMA 50$2.50
    EMA 200$2.39

    MACD

    Line: -0.09Signal: -0.09Hist: -0.01

    ADX

    ADX: 25.6+DI: 14.9-DI: 27.4

    Aroon & PSAR

    Aroon Up32.0
    Aroon Down80.0
    PSAR$2.33

    Bollinger Bands

    Upper Band$2.72
    Lower Band$2.10
    %B Position2551%(Upper)
    Band Width0.26

    RSI (14-Day)

    Neutral
    36.0

    Momentum Oscillators

    Stoch %K13.0
    Stoch %D13.6
    Williams %R-84.6
    ROC (10d)-2.6%
    Momentum-0.06
    CCI (20d)-77.3
    MFI (14d)34.6

    Volatility Measures

    ATR (14d)$0.09(4.2%)
    StdDev (20d)0.15
    Hist Vol37.8%(Moderate)

    Volume Flow

    VWAP$2.25
    OBV64.9M
    AD Line-972.1K
    CMF (20d)0.131

    Volume Metrics

    Avg Vol (20d)2.0M
    Vol Ratio1.1x
    VWMA (20d)$2.43

    Pivot Points

    R3$2.31
    R2$2.28
    R1$2.26
    Pivot Point$2.23
    S1$2.21
    S2$2.19
    S3$2.17

    Advanced Oscillators

    TSI-26.08
    Ultimate Osc48.4
    KST-123.09

    Financial Data

    QuarterJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023
    Total Revenue$57.44M$53.66M$64.58M$60.24M$52.45M$43.24M$56.75M$50.66M$50.52M$43.40M$53.34M$47.25M
    Cost of Revenue$27.91M$25.77M$28.00M$24.56M$23.47M$17.82M$23.42M$19.82M$20.41M$17.09M$20.81M$17.96M
    Gross Profit$29.53M$27.89M$29.75M$28.14M$28.98M$25.42M$27.39M$26.20M$24.67M$21.27M$25.96M$21.82M
    Operating Expenses$31.39M$28.25M$37.22M$34.44M$32.40M$31.28M$34.78M$31.80M$33.94M$34.28M$31.56M$34.54M
    R&D$14.39M$14.53M$16.39M$15.82M$18.90M$16.61M$15.44M$14.01M$14.97M$14.48M$14.29M$16.78M
    SG&A$22.86M$19.95M$20.83M$18.62M$21.18M$20.29M$19.33M$17.79M$18.97M$19.80M$17.27M$16.16M
    Operating Income$-1,858,000$-354,000$-641,000$1.24M$-3,423,000$-5,853,000$-1,449,000$-961,000$-3,836,000$-7,979,000$976,000$-5,243,000
    Interest Income$0$0$0$0$0$0$0$0$0$0$0$0
    Interest Expense$1.71M$1.87M$1.96M$2.12M$2.15M$2.11M$2.05M$2.26M$2.33M$2.23M$2.23M$2.36M
    Income Before Tax$-2,887,000$-1,557,000$-2,065,000$65,000$-5,639,000$-7,644,000$-2,451,000$-2,858,000$-5,831,000$-9,616,000$-1,317,000$-7,208,000
    Income Tax Expense$95,000$91,000$119,000$85,000$76,000$74,000$111,000$76,000$-56,000$74,000$72,000$78,000
    Net Income$-2,982,000$-1,648,000$-2,184,000$-20,000$-5,715,000$-7,718,000$-2,562,000$-2,934,000$-5,775,000$-9,690,000$-1,389,000$-7,286,000
    EBITDA$-712,000$762,000$292,000$2.57M$-3,145,000$-5,227,000$-66,000$-186,000$-3,021,000$-6,751,000$1.56M$-4,167,000
    EBIT$-1,173,000$315,000$-101,000$2.18M$-3,489,000$-5,534,000$-398,000$-598,000$-3,501,000$-7,382,000$912,000$-4,844,000
    * Some calculated fields are derived from available data when not provided by source

    Related GNG Research

    No research available

    Be the first to write about CERS

    Government Contracts

    Gov Obligations (TTM)
    $33.70M
    Gov Obligations / Revenue
    15.2%
    Obligations YoY
    3.3%
    Active Awards
    13
    New Awards (TTM)
    3
    Avg Remaining Term
    21.9 mo

    Top agency: Department of Health and Human Services at 98.8% of trailing twelve month obligations across 2 agencies

    Recent Awards

    Award IDAgencyObligatedStart
    75N98026P00071Department of Health and Human ServicesNational Institutes of Health$225336Mar 9, 2026
    75N90025P00719Department of Health and Human ServicesNational Institutes of Health$115899Sep 12, 2025
    W81K0225PA067Department of DefenseDefense Health Agency$71596Oct 1, 2025

    Federal contract obligations are bookings recorded by the awarding agency, not recognized revenue. They can exceed 100% of revenue and can be negative when contracts are de-obligated. Source: USAspending.gov prime awards, data through Jul 31, 2026.

    News

    A workshop will share one hospital's experience using treated platelets and a clotting product

    Cerus Corporation (Nasdaq: CERS) announced it will host an industry workshop at the 2026 AABB Annual Meeting in Atlanta, Georgia...

    Stock Titan•10/15/26•Neutral

    Cerus Corporation (CERS) - What Are Analysts Saying About This Stock?

    Analysts have issued a consensus "Hold" rating for Cerus Corporation (CERS), with an average 12-month price target of $5.25. The company recently met earnings expectations with a loss of $0.01 per share and revenue...

    MarketBeat•10/14/26•Neutral

    Cerus Corporation Announces Workshop and Abstracts at the 2026 AABB Annual Meeting

    Cerus Corporation (Nasdaq: CERS) announced its participation in the 2026 Association for the Advancement of Blood and Biotherapies (AABB) Annual Meeting, taking place in Atlanta...

    Yahoo! Finance Canada•10/14/26•Bullish

    Cerus Corp. Stock Grades | CERS

    This article provides a stock grade overview for Cerus Corp. (CERS), including its average analyst price target and score, sentiment, and key financial metrics like market value, EPS...

    Barron's•10/6/26•Somewhat-Bearish

    CERS: Cerus Corp. Latest Stock Price, Analysis, News and Trading Ideas

    The article provides the latest stock price for Cerus Corp. (CERS), showing it closed at $2.34 with a slight after-hours gain. It includes investor sentiment and trading ideas...

    Stocktwits•10/3/26•Bullish

    CERS Valuation and Fair Value

    P/E
    -75.1x
    EV/EBITDA
    172.0x
    P/FCF
    -247.8x
    PEG
    0.0x
    P/B
    6.5x
    See GNG's fair value

    CERS Profitability: Margins, ROIC and FCF

    Gross margin
    48.9%
    Operating margin
    -3.2%
    Net margin
    -3.1%
    ROIC
    0.9%
    ROE
    -10.8%
    FCF margin
    -0.8%
    FCF yield
    -0.4%

    CERS Competitors

    CompanyTicker
    National Research CorpNRC
    Neurogene IncNGNE
    Brainsway LtdBWAY
    KamadaKMDA
    Tilray IncTLRY
    Oculis Holding AG Ordinary sharesOCS
    AngioDynamics IncANGO
    Alpha Teknova IncTKNO

    Sector: Healthcare

    CERS Analyst Ratings

    Consensus
    Buy
    Analysts
    3
    Strong Buy
    0
    Buy
    3
    Hold
    0
    Sell
    0
    Strong Sell
    0

    CERS Bull Case vs Bear Case

    Bear case

    • CERS has a -3.1% net profit margin.

    CERS Earnings: Beat Rate and Next Report

    Beat rate
    4 of 8 quarters (50.0%)
    Average surprise
    18.1%
    EPS estimate (fiscal period ending Sep 30, 2026)
    $-0.01
    Estimate revisions (30 days, fiscal period ending Sep 30, 2026)
    0 up, 0 down

    Frequently Asked Questions About CERS

    Does CERS pay dividends?

    Cerus Corporation (CERS) does not currently pay a regular dividend.

    What is CERS's market cap?

    Cerus Corporation (CERS) has a market capitalization of $451.42M with a current stock price of $2.26.

    Related stocks

    Sector: Healthcare

    All stocks starting with C

    Get full access to GNG Research

    Create a free account to access portfolio tracking, advanced tools, and more.

    Create Free AccountLog In